The development of novel HIV-1 vaccines using modified recombinant BCG
Vaccination continues to represent the most effective means of providing immunological protection against infectious disease in human populations. With the World Health Organisation (WHO) reporting over 1.2 million AIDS related deaths in 2014, an efficacious HIV1 vaccine is urgently needed. The UCT...
Main Author: | |
---|---|
Other Authors: | |
Format: | Doctoral Thesis |
Language: | English |
Published: |
University of Cape Town
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/22749 |